<unk>  is a candidate tuberculosis vaccine created by SSI. The<unk>  is composed of the Rv0125 and Rv1196<unk> s derived from Mycobacterium tuberculosis.  Phase I clinical trials were completed in 2005 and Phase II trials are awaited.Kaufmann SHE, McMichael AJ (2005). "Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis". Nature Med. 11 (4 suppl): S33&ndash, S44. doi:10.1038/nm1221. PMID 15812488. Retrieved 2006-04-30.
72F fusion protein
Philadelphia chromosome
Proto-oncogene
Heterochromatin
Short tandem repeat
Triage tag
CARD domain
Extractable nuclear antigens